TipRanks
Go Ultimate55% OFF

ADM Tronics Un (ADMT) AI Stock Analysis

ADMT

ADM Tronics Un

(Other OTC:ADMT)

Select Model
Rating:50Neutral
Price Target:$0.07â–²(8.33% Upside)
Action:reiterated
Date:10/31/26

The overall score is constrained by severe financial distress, including declining revenues, negative margins, and cash burn, which are the most significant risk factors. However, this is partially offset by strong bullish technical momentum and a transformative corporate event involving a strategic capital raise and a high-caliber board overhaul, which introduces potential for a turnaround. The negative P/E ratio and lack of dividend yield further weigh on the score.

Positive Factors
Diversified healthcare technology modelThe combination of electronics manufacturing services, engineering capabilities, and healthcare-related technologies gives ADMT more than one route to generate revenue. A mixed contract-and-proprietary model can support customer diversification and create opportunities to build on specialized medical and industrial expertise over the next several quarters.
Negative Factors
Revenue contractionA roughly 19% TTM sales decline indicates that demand or customer activity has weakened materially across the current revenue base. Sustained contraction would reduce operating leverage, make fixed costs harder to absorb, and limit the resources available for product development, working capital, and growth initiatives.

ADM Tronics Un (ADMT) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%40%ADMT-28.57%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$4.73M
Dividend Yield
―
Average Volume (3M)
15.84K
Price to Earnings (P/E)
-12.1
Beta (1Y)
0.12
Revenue Growth
-2.21%
EPS Growth
-490.00%
Country
US
Employees
30
Sector
General
Sector Strength
55
Industry
Medical - Devices

ADM Tronics Un Business Overview & Revenue Model

Company Description

ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications,...

ADM Tronics Un Financial Statement Overview

Summary

Financial performance is critically weak. Revenue is declining, gross margins have contracted significantly, and the company is generating consistent operating and net losses with a TTM net loss margin of -17.4%. The balance sheet shows a severely eroded equity base and a deeply negative return on equity, while cash flow remains negative, indicating a liquidity crunch with no immediate turnaround in sight.

Income Statement

18Very Negative

Balance Sheet

32Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue3.35M3.35M3.20M2.97M3.68M3.21M
Gross Profit1.36M1.36M1.40M1.12M1.66M1.25M
EBITDA59.65K-60.35K12.29K-732.58K80.35K-1.02M
Net Income-100.37K-100.37K-123.06K-877.22K-96.32K-1.38M
Balance Sheet
Total Assets1.83M1.83M2.13M2.14M3.09M3.35M
Cash, Cash Equivalents and Short-Term Investments255.73K255.73K382.97K537.04K1.00M1.04M
Total Debt741.26K741.26K846.86K918.33K752.69K1.02M
Total Liabilities1.26M1.26M1.46M1.45M1.52M1.98M
Stockholders Equity570.97K570.97K671.35K692.39K1.57M1.37M
Cash Flow
Free Cash Flow-124.06K-124.06K9,978-724.40K125.02K-574.95K
Operating Cash Flow-124.06K-124.06K9,978-709.89K125.02K-574.95K
Investing Cash Flow00-225.75K-14.52K00
Financing Cash Flow-3,180-3,18061.70K257.71K-258.56K66.50K

ADM Tronics Un Technical Analysis

Technical Analysis SentimentPositive
Last Price0.06

Price Trends

50DMA0.05Positive
100DMA0.05Positive
200DMA0.07Negative

Market Momentum

MACD0.00Negative
RSI66.35Neutral
STOCH66.60Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 66.35 is Neutral, neither overbought nor oversold. The STOCH value of 66.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADMT.

ADM Tronics Un Risk Analysis

ADM Tronics Un disclosed 17 risk factors in its most recent earnings report. ADM Tronics Un reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

ADM Tronics Un Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

ADMT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AEMDAEMD61Neutral$8.73M-0.46-123.09%――87.54%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
ADMTADMT50Neutral$4.39M-12.07-56.20%―-2.21%-490.00%
MOVEMOVE41Neutral$210.77M-0.55-9.67%―843.62%21.98%
AMIXAMIX40Underperform$3.55M-0.04-267.73%――64.78%

* General Sector Average

Performance Comparison

0%200%400%ADMTAEMDMOVEAMIXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
ADMT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ADMTADM Tronics Un 0.07-0.02-24.42%
AEMDAethlon5.44-19.16-77.89%
MOVECorvex, Inc.6.682.5963.49%
AMIXAutonomix Medical, Inc.1.81-19.40-91.47%

ADM Tronics Un Corporate Events

Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing

ADM Tronics Un launches strategic private placement and board overhaul

Positive
Oct 30, 2026

ADM Tronics Unlimited, Inc., a long-established technology company in medical electronic devices, specialty water-based chemicals and FDA-registered engineering and contract manufacturing, is based in Northvale, N.J. and serves healthcare and industr...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026